Damora Therapeutics, Inc. (DMRA) Net Income by Year
Damora Therapeutics, Inc. reported a net loss of $209.8M in fiscal year 2025. This represents a decrease of 878.8% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Damora Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
DMRA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
DMRA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Damora Therapeutics, Inc. financials
Frequently Asked Questions
What was Damora Therapeutics, Inc.'s net income in fiscal year 2025?
Damora Therapeutics, Inc. reported a net loss of $209.8M in fiscal year 2025.
How fast is Damora Therapeutics, Inc.'s net income growing?
Damora Therapeutics, Inc. (DMRA) net income fell by 878.8% year over year, from -$21.4M to -$209.8M in fiscal year 2025.
How has Damora Therapeutics, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Damora Therapeutics, Inc. (DMRA) net income went from -$36.5M in fiscal year 2019 to -$209.8M in fiscal year 2025.
What was Damora Therapeutics, Inc.'s net income in the most recent quarter?
Damora Therapeutics, Inc. (DMRA) reported -$31.2M in net income in Q2 2026. This represents a decrease of 807.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Damora Therapeutics, Inc. (DMRA) reported on that line in every period on record.